Matwings Demonstrates Closed-Loop Protein AI Through Four AI-Wet Lab Cycles and 222 Protein Variants

Shanghai Matwings Technology announced its GenSci148 Injection program, highlighting a shift toward iterative protein engineering under real-world drug-development constraints. The provided text does not include efficacy, regulatory status, timelines, or financial terms, limiting expectations for near-term market impact.

Analysis

Shanghai Matwings Technology announced its GenSci148 Injection program, highlighting a shift toward iterative protein engineering under real-world drug-development constraints. The provided text does not include efficacy, regulatory status, timelines, or financial terms, limiting expectations for near-term market impact.